Behavioral Weight Loss Treatment for Individuals With Food Addiction
NCT ID: NCT04311450
Last Updated: 2022-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2021-03-01
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of and Treatment Applied to Food Addiction in a Rural Healthy Behaviors Clinic
NCT03431831
Improving Appetite Regulation in Patients With Obesity
NCT05200520
Recruiting and Retaining Young Adults in Behavioral Weight Loss Treatment
NCT01889082
Novel and Scalable Internet Supplemented Weight Loss Treatment in Primary Care
NCT02578199
Behavioral Weight Loss and Sleep Health Intervention
NCT07255287
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Behavioral Weight Loss
Behavioral: Participants randomized assigned to this arm will received 12 weeks of Behavioral Weight Loss (BWL) counseling.
Behavioral Weight Loss (BWL) counseling
This therapy is a weekly treatment which focuses on making gradual and modest lifestyle changes with goals of establishing regular patterns of eating, setting weekly goals, decreasing caloric intake, developing coping skills, and increasing physical activity.
Waitlist Control
Waitlist Control: Participants assigned to this arm will attend follow-up visits to control for the effect of time. Following completion of post-treatment assessment participants in the waitlist control group will be offered an abbreviated BWL treatment.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Weight Loss (BWL) counseling
This therapy is a weekly treatment which focuses on making gradual and modest lifestyle changes with goals of establishing regular patterns of eating, setting weekly goals, decreasing caloric intake, developing coping skills, and increasing physical activity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets criteria for Food Addiction (based on the self-report score from the Yale Food Addiction Scale)
* Available for the duration of the treatment (3 months)
* Read, comprehend, and write English at a sufficient level to complete study-related materials.
* Availability of internet to participate in study interventions (i.e., electronic SMART scales)
Exclusion Criteria
* Reports active suicidal or homicidal ideation
* Current anorexia or bulimia nervosa
* Endorsing current or history of heart trouble/chest pain.
* Breast-feeding or pregnant, or planning to become pregnant during the study.
* History of stroke or myocardial infarction.
* Current or recent (within 12 months) drug or alcohol dependence
* Currently receiving effective treatment for eating or weight loss, including individual who received bariatric surgery within the past five years
* Currently participating in another clinical study.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale School of Medicine
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000027229
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.